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Abstract
We studied influenza virus M1 protein by generating HeLa and MDCK cell lines that express M1 genetically fused to green fluorescent
protein (GFP). GFP-M1 was incorporated into virions produced by influenza virus infected MDCK cells expressing the fusion protein
indicating that the fusion protein is at least partially functional. Following infection of either HeLa or MDCK cells with influenza A virus
(but not influenza B virus), GFP-M1 redistributes from its cytosolic/nuclear location and accumulates in nuclear dots. Immunofluorescence
revealed that the nuclear dots represent nuclear dot 10 (ND10) structures. The colocalization of authentic M1, as well as NS1 and NS2
protein, with ND10 was confirmed by immunofluorescence following in situ isolation of ND10. These findings demonstrate a previously
unappreciated involvement of influenza virus with ND10, a structure involved in cellular responses to immune cytokines as well as the
replication of a rapidly increasing list of viruses.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Matrix protein (M1) consists of 252 residues and is the
most abundant protein in influenza A virions, with about
3000 molecules per spherical virion (Lamb, 1989). M1
forms a continuous layer at the interior surface of the en-
velope (Nermut, 1972; Schulze, 1972; Booy et al., 1985;
Fujiyoshi et al., 1994) where it is believed to maintain virion
integrity by bridging the viral envelope and the ribonucle-
oprotein (RNP) complex. The interaction of M1 with both
viral integral membrane proteins in the plasma membrane
and newly assembled RNP complex is believed to be crucial
in viral budding. M1 is thought to interact with the lipid
molecules of the envelope and also with the cytoplasmic
tails of envelope proteins, hemagglutinin (HA), neuramini-
dase (NA), and M2. Although the latter interaction remains
controversial (Enami and Enami, 1996; Kretzschmar et al.,
1996; Zhang and Lamb, 1996), it was shown that the cyto-
plasmic tails of HA and NA are essential for correct virus
assembly (Mitnaul et al., 1996; Jin et al., 1997). The inter-
action of M1 with lipids was shown in vitro by the efficient
binding of purified M1 protein to liposomes (Bucher et al.,
1980; Gregoriades, 1980; Gregoriades and Frangione, 1981;
Ruigrok et al., 2000). A minor component of influenza A
virion. NS2 [recently renamed nuclear export protein
(NEP)] also associates with M1 (Yasuda et al., 1993; Ward
et al., 1995).
M1 regulates RNP transport between cytoplasm and nu-
cleus. At the penetration step, the exposure of influenza
virions to acidic pH in endosomes activates the proton
channel activity of M2 protein, which acidifies the viral
interior (Sugrue and Hay, 1991; Pinto et al., 1992). This
induces the dissociation of M1 proteins from RNP (Zhirnov,
1990, 1992; Bui et al., 1996), which is essential for incom-
ing RNP to enter the nucleus (Martin and Helenius, 1991).
At the late stage of infection, M1 binding to the newly
formed RNP complexes in the nucleus induces the export of
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RNP to the cytoplasm (Martin and Helenius, 1991; Bui et
al., 2000). As the binding of M1 inhibits the transport of
RNP into nuclei, the exported M1-RNP complex does not
reenter the nucleus (Whittaker et al., 1996). NS2 (NEP)
probably contributes to the export process (O’Neill et al.,
1998). M1 binds RNA and inhibits the initiation of RNA
synthesis in vitro (Hankins et al., 1990; Watanabe et al.,
1996; Ye et al., 1989; Zvonarjev and Ghendon, 1980) and in
vivo (Perez and Donis, 1998). The accumulation of M1 in
the nucleus is postulated to mediate the suppression of
mRNA synthesis by the polymerase complex of influenza
virus late in infection (Shapiro et al., 1987; Zvonarjev and
Ghendon, 1980).
Other roles of M1 are suggested by its interaction with
host proteins. By immunofluorescence, a portion of M1
colocalizes with actin filaments (Bucher et al., 1989), which
may account for its resistance to detergent extraction (Ava-
los et al., 1997). M1 also associates with histones (Zhirnov
and Klenk, 1997) and the activated C-kinase (RACK 1),
which may be involved in M1 phosphorylation (Reinhardt
and Wolff, 2000). Phosphorylation is the only known post-
translational modification of M1 (Gregoriades et al., 1984,
1990).
Despite its multiple roles in numerous cellular locales,
the intracellular trafficking of M1 is largely uncharacter-
ized. To study M1 in living cells, we constructed a green
fluorescent protein (GFP)/M1 fusion gene and established
cell lines constitutively expressing the fusion protein. GFP
from the jellyfish, Aequorea victoria, is a versatile tool for
studying gene expression and trafficking of fusion protein in
vivo or in situ (reviewed in Lippincott-Schwartz et al.,
1998; Chelbi-Alix et al., 1995; Tsien, 1998). A number of
viral proteins have been fused with GFP and their localiza-
tion was traced in uninfected cells or cells infected with the
source virus (Desai and Person, 1998; Elliott and O’Hare,
1997; Presley et al., 1997; Thomas and Maule, 2000). Using
cells expressing GFP/M1 we found unexpectedly that M1 is
localized to ND10 (nuclear dot 10), subnuclear structures
that have been implicated in the replication of numerous
viruses and in host cell responses to antiviral cytokines
(reviewed in Hodges et al., 1998; Sternsdorf et al., 1997).
Results
Expression of GFP/M1 protein in MDCK and HeLa cells
We established three cell lines expressing a GFP-M1
fusion protein, MDCK-GFP/M10, MDCK-GFP/M5-6, and
HeLa-GFP/M3. In each of these lines the GFP fluorescence
was distributed uniformly throughout the cytoplasm and
nucleus (Fig. 1A). This pattern of distribution was similar to
that of M1 in previous reports where M1 was solely ex-
pressed (Bui et al., 1989, 1996). It should be noted, how-
ever, a patchy and reticular distribution of recombinant M1
was also reported (Zhao et al., 1998).
Immunoblot analysis confirmed that each of the lines
expressed a protein of the predicted molecular mass of the
fusion protein (Fig. 1B). A protein of this mobility could
also be immunoprecipitated from detergent lysates of
MDCK-GFP/M10 cells labeled with [35S]methionine-
[35S]cysteine (data not shown). Based on these results, we
concluded that GFP/M1 fusion protein is correctly ex-
pressed in each of the cell lines.
Incorporation of GFP/M1 into virions
To examine whether GFP/M1 fusion protein maintains
the character of authentic M1 protein, we investigated the
incorporation of GFP/M1 fusion protein into virions by
sucrose density analysis. When the virus preparation from
PR8-infected MDCK-GFP/M5-6 cells was fractionated by
velocity sucrose gradient (20 to 50%) centrifugation, we
detected GFP/M1 by immunoblot analysis using anti-PR8
serum in the fractions 6 to 8 with the greatest amount in the
fraction 6, where the most HA protein was also detected
(Fig. 2A). The fractions 6 to 8 contained the bulk of virus
obtained from nontransfected MDCK cells and also from
MDCK-GFP cells (Fig. 2A) Western blotting analysis using
anti-GFP antibody did not detect GFP protein in the frac-
tions 6 to 8 of virions from GFP-MDCK cells even after
10-fold concentration of virions in the fractions (Fig. 2B).
The sucrose density analysis demonstrates that the GFP/M1
Fig. 1. Expression of GFP/M1 in HeLa-GFP/M3 and MDCK-GFP/M10
cells. Panel A shows diffuse pattern of fluorescence from GFP/M1 in
MDCK-GFP/M10 cells and also the image of phase-contrast microscopy in
the same field. (B) Polypeptides in MDCK-GFP (a), MDCK-GFP/M10 (b),
HeLa-GFP (c), and HeLa-GFP/M3 (d) cells were separated by sodium
dodecyl sulfate–polyacrylamide gel electrophoresis and blotted to PVDF
membranes. GFP/M1 protein on the membranes was detected by anti-PR8
serum. The positions of molecular standards (kDa) are indicated at right.
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is specifically incorporated into influenza virus particles and
its incorporation does not grossly modify virus sedimenta-
tion.
Incorporation was also suggested by the observation of
fluorescent particles on erythrocytes when erythrocytes
were incubated with the supernatants of PR8-infected
MDCK-GFP/M5-6 cells (data not shown).
We conclude from these data that the genetic fusion of
GFP to M1 does not detectably alter its intracellular distri-
bution, ability to associate with other viral structural pro-
teins, or contribution to virus structure.
Influenza virus infection redistributes GFP/M1 to nuclear
dots
We next examined the distribution of GFP/M1 in live
PR8-infected MDCK-GFP/M5-6 cells (Fig. 3). We noted
the first alteration in GFP/M1 distribution at 4 h p.i. after
which fluorescence began to concentrate in nuclear dots. By
10 h p.i. nearly all infected cells exhibited this pattern of
fluorescence (Fig. 3H). Nuclear dots were distributed
throughout nucleoplasm and were excluded from nucleoli
(Fig. 3). Some cells continued to exhibit uniform fluores-
cence (Fig. 4A). Staining with anti-PR8 serum revealed that
these cells were uninfected, and the accumulation of
GFP/M1 in nuclear dots was only observed in infected cells
(Fig. 4A and C). This demonstrates that the redistribution of
GFP/M1 to nuclear dots is a direct result of virus infection
and cannot be attributed to the effects of soluble cytokines
released by infected cells. Similar findings were made with
GFP/M1 expressing HeLa cells (data not shown).
To confirm that the recruitment of GFP/M1 to nuclear
dots reflects the properties of M1 and not GFP, we exam-
ined the effect of PR8 infection on HeLa-GFP and MDCK-
GFP cells. The uniform diffuse pattern of fluorescence in
MDCK-GFP and HeLa-GFP cells was not modified (Fig.
4B and D), even following 24-h infection (data not shown).
These results indicate that the M1 moiety of GFP/M1 fusion
protein is required for localization of GFP/M1 to nuclear
dots.
Influenza B virus does not induce punctate accumulation
of GFP/M1
To characterize the requirements for movement of
GFP/M1 to nuclear dots, we examined the effects of other
influenza viruses on GFP/M1 distribution. MDCK-GFP/
M5-6 cells were infected with A/Aichi/2/68, which be-
longs to H3 influenza A virus subtype or with influenza B
virus, B/Yamagata/1/73. The amino acid sequence of M1
protein of PR8 shows different homology with that of
these viruses, 96.8% and 29.0% homology with A/Aichi/
2/68 and B/Yamagata/1/73, respectively. Ten h p.i., nu-
clear dots of GFP/M1 were clearly observed in A/Aichi/
2/68-infected cells, whereas no punctate pattern was in
the cells infected with B/Yamagata/1/73 (Fig. 5) (or cells
infected with B/Bangkok/163/90). Notably, the nuclear
dots induced by A/Aichi/2/68 were smaller and more
numerous than those induced by PR8. Smaller nuclear
dots were observed cells infected with A/Udorn/307/72,
another H3 subtype virus.
Fig. 2. Sucrose gradient centrifugation analysis of virions grown in
MDCK-GFP/M5-6 cells. Sucrose gradient centrifugation analysis of viri-
ons grown in MDCK-GFP/M5-6, MDCK-GFP, and MDCK cells were
infected with PR8 for 15 h and virions were prepared from the supernatants
of these cells. The virions were overlaid onto linear 20–50% sucrose
gradients and centrifuged. The gradients were fractionated from the bot-
tom. (A) Polypeptides in each fraction were analyzed by immunoblot
analysis using anti-PR8 serum. PR8-infected cells (IC) were also analyzed.
(B) Virions in fractions 6, 7, and 8 were pelleted to concentrate and
solubilized by sodium dodecyl sulfate–polyacrylamide gel electrophoresis
sample buffer. The solubilized virions were analyzed by immunoblot
analysis using anti-GFP monoclonal antibody. PR8-infected MDCK,
MDCK-GFP, and MDCK-GFP/M5-6 cells were also analyzed.
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Identification of GFP/M1 containing nuclear dots
Influenza virus infection is known to alter the architec-
ture of nuclear substructures, including PML-containing
ND10 (Guldner et al., 1992) and SC35-containing speckled
domains (Fortes et al., 1995). We examined the relationship
between GFP/M1 containing nuclear dots and these struc-
tures using antibodies specific for PML or SC35. Staining of
HeLa cells with each antibody revealed nuclear dots, with a
greater number detected by anti-SC35 antibody. As reported
previously (Guldner et al., 1992; Fortes et al., 1995; Wolff
et al., 1998), PR8 infection increased the number and de-
creased the size of PML- and SC35-containing dots (data
not shown). The expression of GFP/M1 in HeLa cells did
not affect the staining pattern with anti-SC35 and anti-PML
antibodies.
Following PR8 infection, GFP/M1 containing dots sel-
dom coincided staining by anti-SC35 antibodies (Fig. 6A,
Fig. 3. Time course of nuclear punctate dot induction of GFP/M1 in PR8 infected cells. MDCK-GFP/M5-6 cells were adsorbed with PR8 of moi 10 at 4°C
and then incubated at 37°C. Images of phase-contrast (A, C, E, and G) and conventional fluorescence (B, D, F, and H) microscopy of the infected cells were
taken in the almost same field at every 1-h incubation. No obvious change was observed until 4-h incubation, when accumulation of GFP/M1 in nuclear dots
began to appear. Images acquired 4, 6, 8 and 10 h p.i. are shown. Arrowheads identify identical cell for points of reference. moi, multiplicity of infection.
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C, and E). Even in the infrequent coinciding dots, the size of
GFP/M1 dot and that of coinciding speckled domains were
grossly different. In contrast, the nuclear dots of GFP/M1
were often almost completely superimposable with dots
stained with anti-PML antibody at least until 10 to 15 h p.i.
(Fig. 6B, D, and F).
We next examined whether M1 produced by influenza
virus localizes to ND10. Although M1 protein in influenza
virus-infected cells distributes uniformly throughout cyto-
plasm and nucleus (Fig. 7C) it is possible that the excess of
M1 in the nucleus obscures the M1 localized in nuclear dots.
To test this idea, PR8-infected MDCK or HeLa cells at-
tached to coverslips were subjected to a four-step extraction
procedure originally developed to isolate the nuclear matrix,
but which also isolates components of nuclear dots (Anton
et al., 1999; Staufenbiel and Deppert, 1984). Indeed, M1
was localized to nuclear dots following this procedure, as
was GFP/M1 (Fig. 7A, B, C, and D). The staining of
PR8-infected HeLa cells with anti-PML antibody after the
extraction revealed the colocalization of M1 with ND10
(Fig. 8).
It should be noted that the staining intensity with anti-
PML antibody was different between M1 antigen-positive
and negative cells. The dots of PML were much clearer in
M1 antigen-negative cells, which might reflect the previous
observation that the size and number of ND10 is altered in
influenza virus-infected cells (Guldner et al., 1992).
Based on these results, we concluded that a fraction of
authentic M1 protein localize in ND10.
Colocalization of NS1 and NS2 proteins with M1 protein
in ND10
The infection-dependent localization of GFP/M1 to
ND10 suggests that other viral proteins are involved in this
process. As NS2 protein is known to associate with M1
protein (Yasuda et al., 1993; Ward et al., 1995) and NS1
induces the redistribution of nuclear substructure (Fortes et
al., 1995; Wolff et al., 1998), these two proteins are the
prime candidates for participating in M1 localization to
ND10. We therefore examined the distribution of NS1
and/or NS2 with M1 following the four-step extraction
procedure using anti-NS1 or anti-NS2 antibodies. This re-
vealed that both NS1 and NS2 were present in M1-contain-
ing ND10 (Fig. 9). This observation suggests the involve-
ment of NS1 and/or NS2 in the localization of M1 to ND10.
Discussion
In the present report we demonstrate that it is possible to
label influenza virus M1 with GFP and maintain M1 func-
tion as demonstrated most convincingly by incorporation of
M1/GFP into virions. These encouraging results have
prompted our attempts to generate influenza virus geneti-
cally engineered to express GFP/M1, which would be a
valuable tool with numerous applications, although we have
not yet succeeded.
Unexpectedly, we found that GFP/M1 localizes to ND10
following infection with influenza A viruses. On the other
Fig. 4. Punctate accumulation of GFP/M1 appeared only in viral antigen-positive cells. MDCK-GFP/M10 (A and C) and MDCK-GFP (B and D) cells were
infected with PR8 at moi 10. The cells were fixed and permeabilized at 10 h p.i., and then stained with anti-PR8 serum followed by rhodamine-conjugated
secondary antibody. The images of conventional fluorescence microscopy of GFP/M1 (A), GFP (B), and rhodamine (C, D) are shown. Arrows identify an
uninfected cell. Arrowhead identifies an cell not expressing the GFP/M1 fusion protein. moi, multiplicity of infection; GFP, green fluorescent protein.
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hand, the infection with influenza B viruses does not induce
the relocalization of GFP/M1. Influenza B virus is highly
similar to influenza A virus in its replication strategy and
effects on infected cells. Natural stable reassortants between
influenza A and B viruses, however, have never been ob-
served (Ghenkina and Ghendon, 1979; Lamb and Krug,
1996) despite that both types infect humans. The most likely
reason of this phenomenon is the inability of influenza A
virus proteins to interact functionally with influenza B virus
proteins, as shown in the case of RNP protein components
(Crescenzo-Chaigne et al., 1999; Jambrina et al., 1997).
Thus, these findings strongly suggest that the virus-induced
redistribution of GFP/M1 is based on the interaction of
GFP/M1 with viral proteins and not general alterations in
the cell that accompany viral infection.
Although GFP/M1 should maintain important elements
of native structure, as indicated by its incorporation into
virions, it appears to differ from authentic M1, which unlike
M1/GFP less strongly localizes to ND10. This difference
may, however, reflect temporal differences in expression
and not differences in structure/function. The targeting of
M1/GFP to ND10 may be favored by virtue of the fact that
it is presynthesized by cells. In this scenario, the association
of newly synthesized M1 with viral proteins would disfavor
its transport to ND10. It is also possible that the attachment
of GFP increases the propensity of M1 to localize to ND10
by either direct (e.g., binding to a ND10 protein) or indirect
(e.g., increasing association with a protein that binds to
ND10) mechanism. Even if this is correct, we note that the
fusion protein exaggerates the normal propensity of M1 to
localize to ND10.
The colocalization of both of NS1 and NS2 to M1-
containing ND10 suggests the involvement of these proteins
in the localization of M1 and M1-GFP to ND10. Further
experiments are required to determine whether these pro-
teins alone, or in conjunction are able to induce M1 local-
ization to ND10. It will be of interest to determine to what
extent these proteins possess intrinsic ND10 localization
Fig. 5. A/Aichi/2/68 but not B/Yamagata/1/73 induces the accumulation of GFP/M1 in nuclear dots. HeLa-GFP/M5-6 cells were infected with A/Aichi/2/68
(A, B, and C) or B/Yamagata/1/73 (D, E, and F) at moi 10 for 10 h. The infected cells were fixed and permeabilized, and then stained with anti-H3 or anti-B
serum followed by rhodamine-conjugated secondary antibody. The images of phase-contrast microscopy (A and D) and those of conventional fluorescence
microscopy of rhodamine (C and F) and GFP/M1 (B and E) are shown. A, B, and C, and D, E, and C were taken in the same field respectively. moi,
multiplicity of infection.
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signals. If, for example, NS2 possesses such a signal, a
relatively simple scenario would be that M1 is recruited to
ND10 by virtue of its binding to NS2.
ND10 is a nuclear substructure originally discovered as
targets of autoantibodies in patients suffering from the au-
toimmune disease primary biliary cirrhosis (Sternsdorf et
al., 1997). A number of proteins are known to be associated
with ND10 including PML, SP100, SUMO-1 (PIC-1),
NDP-55, NDP-52, and int-6 (reviewed in Hodges et al.,
1998). Of these proteins, PML is best characterized and is
believed to be involved in negative growth regulation and
apoptosis (Wang et al., 1998b; Torii et al., 1999; Quignon et
al., 1998; Mu et al., 1994; Koken et al., 1995; Liu et al.,
1995; Le et al., 1996). Mice with a targeted deletion of this
gene are more susceptible to tumorigenesis and infections
(Wang et al., 1998a). ND10 is a target of a rapidly growing
list of viruses. The function of ND10 in viral replication is
obscure, but it has been proposed to be involved in coordi-
nating the expression and replication of viral genomes. A
number of DNA viruses, such as SV40, adenovirus 5, and
HSV-1 begin replication in the periphery of ND10 (re-
viewed in Sternsdorf et al., 1997; Maul, 1998). Viral pro-
teins like tax of HTLV-1, E4-ORF3 of adenovirus 5, IE72
(IE1) of HCMV, and ICP0 (Vmw110) of HSV-1 have been
reported to interact with ND10 and alter its structure (Des-
bois et al., 1996; Everett and Maul, 1994; Doucas et al.,
1996; Korioth et al., 1996). The degradation of PML by
herpesvirus was also reported (Chelbi-Alix and de The,
1999).
It was previously reported that influenza virus infection
alters the size and the number of ND10 (Guldner et al.,
1992), a finding we confirmed. The expression of PML is
induced by interferons (Chelbi-Alix et al., 1995; Lavau et
al., 1995; Stadler et al., 1995) and overexpression of PML
suppresses the replication of several viruses including in-
fluenza virus (Chelbi-Alix et al., 1998). These results sug-
gest an important role of PML in the interferon-induced
antivirus state.
We propose that the accumulation of M1, NS1, and NS2
in ND10 of influenza virus-infected cells induces the dys-
function of ND10 or proteins associated with ND10 like
PML, thereby interfering with the interferon-induced anti-
viral state, including the induction of apoptosis. In this
scenario, influenza virus would utilize a supplementary anti-
interferon mechanism in addition to that mediated by NS1
(Garcia-Sastre et al., 1998; Talon et al., 2000; Bergmann et
al., 2000). Another possible role of PML in virus infection
is suggested by a recent report that showed PML controls
expression of genes crucial for MHC class l-restricted an-
tigen presentation (Zheng et al., 1998). Influenza virus
might interfere with the immune response of hosts by dis-
rupting the function PML or ND10.
In summary, our data strongly suggest a novel interaction
of M1, NS1, and NS2 with ND10, an important nuclear
structure. Further elucidation of this interaction should shed
new light on the role of ND10 in influenza virus infections.
Materials and methods
Cell cultures, viruses, and virus infection
Influenza viruses, A/PR/8/34 (PR8), A/Aichi/2/68,
A/udorn/307/72, B/Yamagata/1/73, and B/Bangkok/163/90
were grown in the allantoic cavities of 10-day-old embry-
onated chicken eggs and allantoic fluids were used as virus
stocks. Virus stocks were aliquoted and stored at 80°C.
MDCK and HeLa cells were passaged in Eagle’s mini-
mum essential medium (MEM) containing 10% fetal calf
serum (FCS). MDCK-GFP/M10, MDCK-GFP/M 5-6,
HeLa-GFP/M3, MDCK-GFP, and HeLa-GFP cells were
passaged in MEM containing 10% FCS and 1 mg/ml G 418
(Nacalai Tesque).
Cells washed with phosphate-buffered saline (PBS) were
infected at 4 or 37°C with influenza viruses in MEM con-
taining 1% bovine serum albumin (BSA) at moi (multiplic-
ity of infection) 10 for 30 min at 37°C and 1 h at 4°C. At the
end of adsorption, cells were washed with PBS and incu-
bated further in MEM at 37°C.
Antibodies
Monoclonal antibodies anti-PML (PG-M3) and anti-
SC35 (SC35) were purchased from Santa Cruz Biotech-
nology and BD PharMingen, respectively. PG-M3 is human
PML-specific antibody and does not bind to PML in MDCK
cells. Anti-GFP monoclonal antibodies were purchased
from Clontech (JL-8). For anti-M1antibodies, rabbit serum
raised against recombinant M1 protein, which was kindly
provided by Dr. M. Enami (Kanazawa University School of
Medicine, Japan), and monoclonal antibody M2/1C6 were
used. Rabbit serum raised against NP protein of PR8, re-
combinant NS1 protein, and recombinant NS2 were gener-
ous gifts of Dr. S. Tamura (National Institute of Infectious
Diseases, Japan), Dr. M. Enami, and Dr. A. Ishihama (Na-
tional Institute of Genetics, Japan), respectively. Rabbit sera
against whole viruses, anti-A/udorn/307/72 (kindly pro-
vided by Dr. K. Shimizu, Nihon University School of Med-
icine, Japan), anti-B/Yamagata/1/73 (kindly provided by
Dr. T. Odagiri, National Institute of Infectious Diseases,
Japan), and anti-PR8 were also used. Anti-A/udorn/72 and
anti-B/Yamagata/1/73 sera were used as anti-H3 subtype
and anti-B type antibodies, respectively.
Construction of pGFP/M1
Plasmid pGFP/M1, expression vector for GFP/M1 fusion
protein, was constructed as follows. A DNA fragment con-
taining coding region of M1 gene was amplified from pT3/
PR8-M (kindly provided by Dr. M. Enami) by polymerase
chain reaction using two primers, M-F (AGATCTAT-
GAGTCTTCTAACCGAG) and M-R (TCCCCCGGGT-
CACTTGAACCGTTGCAT). The amplified DNA frag-
ment and pEGFP-C1, a GFP fusion protein expression
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Fig. 6. Nuclear dots of GFP/M1 coincide with PML-containing ND10. HeLa-
GFP/M3 cells were infected with PR8 at moi 10 for 15 h, fixed and permeabilized,
and then stained with anti-SC35 or anti-PML monoclonal antibody followed by
rhodamine-conjugated secondary antibody. The fluorescence of GFP/M1 (C and
D) and rhodamine (A and B) of the stained cells were observed simultaneously by
laser confocal microscopy. A and C are paired micrographs of anti-SC35 antibody
stained cells. B and D are paired micrographs of anti-PML antibody stained cells.
E and F are merged images of A and C, and B and D, respectively. moi,
multiplicity of infection.
Fig. 8. Nuclear dots of authentic M1 also colocalize with ND10. HeLa cells were
infected with PR8 at moi 10 for 6 h and then in situ extracted. The residual
structures were fixed and stained with anti-M1 rabbit serum and anti-PML mouse
monoclonal antibody followed by rhodamine-conjugated anti-rabbit IgG and flu-
orescein isothiocyanate (FITC)-conjugated anti-mouse IgG antibodies. The stained
cells were observed with conventional fluorescence microscope for rhodamine (A)
and FITC (B). The black and white pictures obtained by CCD-camera were false
colored (red, rhodamine; green, FITC) and merged (C). moi, multiplicity of
infection; ND10, nuclear dot 10.
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vector obtained from Clontech, were double-digested with
BglII and SmaI. The digested fragment and the vector were
ligated to obtain pGFP/M1 in which GFP gene was attached
to the N-terminus of M1 protein. The fusion protein ex-
pressed from pGFP/M1 should have an additional 5 amino
acids (Ser-Gly-Leu-Arg-Ser) derived from polylinker re-
gion of pEGFP-C1 between asparagine of GFP C-terminus
and methionine of M1 N-terminus.
Establishment of cell lines expressing GFP/M1 fusion
protein
Plasmid pGFP/M1 was introduced into MDCK and
HeLa cells with liposome-mediated transfection using
DOTAP (Boehringer Mannheim). The transfected cells
were cultured in MEM containing 10% FCS and 2 mg/ml
G418 to select the cells that express GFP/M1 fusion protein
constitutively. The survived cells were cloned by limiting
dilution method or colony isolation, and each clone was
tested for the expression of GFP/M1 by fluorescence mi-
croscopy and flow cytometry using FACScan (Becton Dick-
inson). MDCK-GFP/M10, MDCK-GFP/M5-6, and HeLa-
GFP/M3 were chosen because of their moderate intensity of
fluorescence than others. As a control plasmid, pEGFP-C1
was also introduced to MDCK and HeLa cells and cell lines
MDCK-GFP and HeLa-GFP, which express authentic GFP,
were established by the same way as above.
Immunoblot analysis
Polypeptides in samples were separated under reducing
conditions by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). The separated polypeptides
were electrotransferred onto PVDF membranes (Pall) by the
semidry method. The membranes were then incubated in
blocking buffer [TBS-T (20 mM Tris-HCl (pH 7.6), 137
mM NaCl, 0.1% Tween 20) containing 10% skim milk] for
1 h and washed with TBS-T. They were subsequently in-
cubated with rabbit sera or monoclonal antibodies for 1 h
and washed with TBS-T. Finally, secondary horseradish
peroxidase-conjugated anti-rabbit or anti-mouse IgG anti-
bodies (Amersham Pharmacia Biotech) were applied to the
membranes. After washing with TBS-T, the peroxidase-
conjugated antibodies on the membranes were detected by
using the ECL system (Amersham Pharmacia Biotech) ac-
cording to the manufacturer’s manual. The images of the
chemiluminescence were captured with a CCD-camera
(LAS-1000, Fujifilm).
Sucrose gradient centrifugation analysis of virus
The supernatants of influenza virus infected cells were
clarified by low-speed centrifugation and then the virions
were pelleted by the centrifugation of 200,000  g for 2 h
at 4°C. The pelleted virions were resuspended in NTE
Fig. 9. Colocalization of NS1 and NS2 proteins with M1 protein in extracted cells. MDCK cells were infected with PR8 at moi 10 for 12 h and were extracted
in situ by a four-step procedure and the residual structures were fixed. The structures were stained with anti-M1 monoclonal antibody and anti-NS1 (A, B,
and C) or anti-NS2 serum (D, E, and F) followed by fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG and rhodamine-conjugated anti-rabbit IgG
antibodies. The stained cells were observed with conventional fluorescence microscope for FITC (A and D) and rhodamine (B and E). The black and white
pictures obtained by CCD-camera were false colored (green, FITC; red, rhodamine) and merged (C and F).
37Y. Sato et al. / Virology 310 (2003) 29–40
buffer [10 mM Tris (pH 7.4), 100 mM Na Cl, 1 mM EDTA]
and applied on a linear 20–50% sucrose gradient. The
fractionation of virions by velocity sucrose gradient centrif-
ugation was done in a RPS56T (Hitachi) rotor (35,000 rpm,
1 h, 4°C). The gradients were fractionated from the bottom
into 250-l samples. For the immunoblot analysis, 5 l of
each fraction was solubilized with SDS-PAGE sample
buffer and boiled for 5 min and applied to 11% polyacryl-
amide-SDS gels. To analyze concentrated virions in the
fractions, 50 l of each fraction was centrifuged at 40,000
rpm for 90 min using an RP80 AT rotor (Hitachi) and
SDS-PAGE sample buffer was added to the pelleted virions.
The solubilized virions were analyzed by immunoblot tech-
nique.
In situ cell extraction
Cells cultured on glass coverslips were extracted by the
method of Staufenbiel and Deppert (1984). Briefly, cells
were washed with KM buffer [10 mM N-morpholinoeth-
anesulfonic acid (pH 6.2), 10 mM NaCl, 1.5 mM MgCl2,
10% glycerol, 10 g/ml aprotinin] and incubated on ice in
KM buffer containing 1% NP40, 1 mM EGTA, 5 mM
dithiothreitol (first extraction step). After wash with KM
buffer, structures on coverslips were incubated at 37°C in
KM buffer containing 50 g/ml DNase I (second extraction
step). The DNase I solution was removed and KM buffer
containing 2 M NaCl, 1 mM EGTA, and 5 dithiothreitol was
added and incubated at 4°C (third extraction step). Then the
structures were washed with KM buffer and incubated at
37°C in KM buffer containing 50 g/ml DNase I and 50
g/ml RNase A (fourth extraction step).
Indirect immunofluorescence microscopy
Cells were grown on glass coverslips in MEM con-
taining 10% FCS. Where indicated, cells were infected
with influenza viruses for the indicated times. After
washing with PBS, cells were fixed for 10 min in PBS
containing 4% paraformaldehyde, permeabilized for 10
min in PBS containing 0.2% Triton X-100, and incubated
for 30 min in PBS containing 3% BSA (3% BSA-PBS).
Subsequently, cells were stained for 1 h with primary
antibodies or sera diluted in 3% BSA-PBS. The cells
were washed and incubated with Alexa 350-, rhodamine,
or fluorescein isothiocyanate (FITC)-conjugated goat an-
ti-rabbit immunoglobulin G (IgG) (Molecular Probe or
Cappel), and/or Alexa 350-, rhodamine-, or FITC-conju-
gated goat anti-mouse IgG (Molecular Probe or Cappel)
diluted in 3% BSA-PBS. Finally, the coverslips were
washed with PBS and mounted in Fluoromount-G
(Southern Biotechnology Associates). If it is not stated,
cells were viewed on an Olympus IX70 conventional
fluorescence microscope for immunofluorescence analy-
sis, and images were photographed with PROVIA (Fuji-
film) or captured with a digital camera (PDMC Ie/OL,
Olympus or Orca-ER, Hamamatsu Photonics). For con-
focal laser scanning microscopy, a Zeiss LSM410 invert
microscope equipped with 63 objective lens was used.
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Fig. 7. Nuclear dots of authentic M1 protein in extracted cells. MDCK-GFP/M10 (A and B) and MDCK (C and D) cells were infected with PR8 at moi 10
for 10 h. The infected MDCK-GFP/M10 cells were extracted in situ by a four-step procedure and the residual structures were fixed and observed by
phase-contrast (A) and conventional fluorescence microscopy (B) in the same field. The infected MDCK cells were fixed before (C) or after (D) in situ
extraction, and then stained with anti-M1 monoclonal antibody (C and D) followed by rhodamine-conjugated anti mouse IgG (C and D). The stained cells
were observed with conventional fluorescence microscope for rhodamine (C and D). moi, multiplicity of infection.
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